NF knows no boundaries, and that includes Asia, which accounts for 60% of the world’s population. We’re pleased to announce that the Children’s Tumor Foundation, in partnership with WuXi AppTec, is spreading awareness of NF in China at the 2019 WuXi Healthcare Forum being held this week in Shanghai. WuXi AppTec is a global pharmaceutical and medical device company based in China, and Richard Soll, Senior Advisor, Strategic Initiatives, WuXi AppTec, sits on the national board of the Children’s Tumor Foundation. The WuXi Healthcare Forum brings together innovators, clinicians, healthcare providers, and technologists together to shape the future of healthcare. The event focuses on precision diagnostics, breakthrough therapies, genomics, and new technologies. While neurofibromatosis is still relatively unknown in China and throughout Asia, CTF’s presence at the Forum will help expand knowledge of NF among these influential attendees. To learn more about the WuXi Healthcare Forum, visit here.
Expanding NF Awareness in China at the WuXi Healthcare Forum
